MeSH Review:
Carcinosarcoma
- A unique complement derived chemotactic factor for tumor cells. Romualdez, A.G., Ward, P.A. Proc. Natl. Acad. Sci. U.S.A. (1975)
- C-type virus particles in urethan-induced pulmonary and renal carcinomas, in cell-graft-transmitted carcinosarcomas, and in filtrate-induced lymphomas in mice. Gross, L., Feldman, D., Dreyfuss, Y., Ehrenreich, T., Moore, L.A. Cancer Res. (1976)
- Effects of prostacyclin on tumor cell-induced platelet aggregation. Menter, D.G., Onoda, J.M., Taylor, J.D., Honn, K.V. Cancer Res. (1984)
- Opening the blood-brain and blood-tumor barriers in experimental rat brain tumors: the effect of intracarotid hyperosmolar mannitol on capillary permeability and blood flow. Hiesiger, E.M., Voorhies, R.M., Basler, G.A., Lipschutz, L.E., Posner, J.B., Shapiro, W.R. Ann. Neurol. (1986)
- Response of Walker 256 carcinosarcoma cells to 12-O-tetradecanoylphorbol 13-acetate: possible regulation by endogenous cyclooxygenase metabolites. Varani, J., Perone, P. J. Natl. Cancer Inst. (1985)
- Antitumor activity of a polychlorinated biphenyl mixture, Aroclor 1254, in rats inoculated with Walker 256 carcinosarcoma cells. Kerkvliet, N.I., Kimeldorf, D.J. J. Natl. Cancer Inst. (1977)
- Arachidonate lipoxygenases as essential regulators of cell survival and apoptosis. Tang, D.G., Chen, Y.Q., Honn, K.V. Proc. Natl. Acad. Sci. U.S.A. (1996)
- Chemotactic factor for tumor cells derived from the C5a fragment of complement component C5. Orr, W., Phan, S.H., Varani, J., Ward, P.A., Kreutzer, D.L., Webster, R.O., Henson, P.M. Proc. Natl. Acad. Sci. U.S.A. (1979)
- Walker 256/S carcinosarcoma causes osteoporosis-like changes through ectopical secretion of luteinizing hormone-releasing hormone. Waki, Y., Nomura, M., Kasugai, S., Ohya, K., Miyamoto, K. Cancer Res. (1999)
- Cisplatin in gynecologic carcinosarcoma. Willemse, P.H., Bouma, J., Hollema, H. J. Clin. Oncol. (1992)
- Enhanced therapeutic effect against liver W256 carcinosarcoma with temperature-sensitive liposomal adriamycin administered into the hepatic artery. Zou, Y., Yamagishi, M., Horikoshi, I., Ueno, M., Gu, X., Perez-Soler, R. Cancer Res. (1993)
- Toxicity of intrathecally administered cytotoxic drugs and their antitumor activity against an intrathecal Walker 256 carcinosarcoma model for meningeal carcinomatosis in the rat. Kooistra, K.L., Rodriguez, M., Powis, G. Cancer Res. (1989)
- Molecular evidence that most but not all carcinosarcomas of the uterus are combination tumors. Wada, H., Enomoto, T., Fujita, M., Yoshino, K., Nakashima, R., Kurachi, H., Haba, T., Wakasa, K., Shroyer, K.R., Tsujimoto, M., Hongyo, T., Nomura, T., Murata, Y. Cancer Res. (1997)
- Binding of formyl peptides to Walker 256 carcinosarcoma cells and the chemotactic response of these cells. Rayner, D.C., Orr, F.W., Shiu, R.P. Cancer Res. (1985)
- Endothelial cell damage by Walker carcinosarcoma cells is dependent on vitronectin receptor-mediated tumor cell adhesion. Shaughnessy, S.G., Lafrenie, R.M., Buchanan, M.R., Podor, T.J., Orr, F.W. Am. J. Pathol. (1991)
- Diacylglycerols and the protein kinase inhibitor H-7 suppress cell polarity and locomotion of Walker 256 carcinosarcoma cells. Keller, H.U., Zimmermann, A., Niggli, V. Int. J. Cancer (1989)
- Tumor visualization with a radioiodinated phospholipid ether. Counsell, R.E., Schwendner, S.W., Meyer, K.L., Haradahira, T., Gross, M.D. J. Nucl. Med. (1990)
- Influence of interleukin-2 infusion on cell cycle kinetics in the Walker-256 carcinosarcoma. Wan, J.M., Bistrian, B.R., Figoni, M.A., Istfan, N.W. J. Leukoc. Biol. (1994)
- Apoptosis of W256 carcinosarcoma cells of the monocytoid origin induced by NDGA involves lipid peroxidation and depletion of GSH: role of 12-lipoxygenase in regulating tumor cell survival. Tang, D.G., Honn, K.V. J. Cell. Physiol. (1997)
- Pulmonary blastoma, carcinosarcoma and spindle-cell carcinoma: an immunohistochemical study of keratin intermediate filaments. Addis, B.J., Corrin, B. J. Pathol. (1985)
- Angiogenesis in carcinosarcomas of the uterus: differences in the microvessel density and expression of vascular endothelial growth factor between the epithelial and mesenchymal elements. Emoto, M., Iwasaki, H., Ishiguro, M., Kikuchi, M., Horiuchi, S., Saito, T., Tsukamoto, N., Kawarabayashi, T. Hum. Pathol. (1999)
- O6-(4-bromothenyl)guanine reverses temozolomide resistance in human breast tumour MCF-7 cells and xenografts. Clemons, M., Kelly, J., Watson, A.J., Howell, A., McElhinney, R.S., McMurry, T.B., Margison, G.P. Br. J. Cancer (2005)
- Carcinosarcoma of the renal pelvis with extension into the renal vein and inferior vena cava. Tarry, W.F., Morabito, R.A., Belis, J.A. J. Urol. (1982)
- Carcinosarcoma of the ovary in a patient with a germline BRCA2 mutation: evidence for monoclonal origin. Sonoda, Y., Saigo, P.E., Federici, M.G., Boyd, J. Gynecol. Oncol. (2000)
- Gastrin-releasing peptide receptors in normal and neoplastic human uterus: involvement of multiple tissue compartments. Fleischmann, A., Waser, B., Gebbers, J.O., Reubi, J.C. J. Clin. Endocrinol. Metab. (2005)
- Localization of the VEGF and angiopoietin genes in uterine carcinosarcoma. Emoto, M., Charnock-Jones, D.S., Licence, D.R., Ishiguro, M., Kawai, M., Yanaihara, A., Saito, T., Hachisuga, T., Iwasaki, H., Kawarabayashi, T., Smith, S.K. Gynecol. Oncol. (2004)
- MDM2 and CDK4 expression in carcinosarcoma of the esophagus: comparison with squamous cell carcinoma and review of the literature. Nikitakis, N.G., Drachenberg, C.B., Papadimitriou, J.C. Exp. Mol. Pathol. (2002)
- Topical chemotherapy of intradermal Walker 256 carcinosarcoma with diaziquone and doxorubicin in the rat. Moore, D.J., Powis, G., Richardson, R.L., Pittelkow, M.R. Cancer Res. (1985)
- The chemotactic response of tumor cells. A model for cancer metastasis. Lam, W.C., Delikatny, E.J., Orr, F.W., Wass, J., Varani, J., Ward, P.A. Am. J. Pathol. (1981)
- Changes in brain amines associated with cancer anorexia. Chance, W.T., von Meyenfeldt, M.F., Fischer, J.E. Neuroscience and biobehavioral reviews. (1983)
- Distinct cadherin profiles in special variant carcinomas and other tumors of the breast. Han, A.C., Soler, A.P., Knudsen, K.A., Salazar, H. Hum. Pathol. (1999)
- Adjuvant ifosfamide and cisplatin in patients with completely resected stage I or II carcinosarcomas (mixed mesodermal tumors) of the uterus: a Gynecologic Oncology Group study. Sutton, G., Kauderer, J., Carson, L.F., Lentz, S.S., Whitney, C.W., Gallion, H. Gynecol. Oncol. (2005)